Successful treatment of fingolimod-associated macular edema with intravitreal triamcinolone with continued fingolimod use

Sophie Thoo, Sudha Cugati, Andrew Lee, Celia Chen

    Research output: Contribution to journalArticlepeer-review

    22 Citations (Scopus)

    Abstract

    The occurrence of macular edema as an adverse effect of fingolimod is well documented. Treatment modalities used to manage fingolimod-associated macular edema (FAME) have included nonsteroidal anti-inflammatory agents and sub-tenon injection. We describe two cases where intravitreal injection is used to successfully treat FAME in patients who were previously unsuccessfully treated with topical nonsteroidal anti-inflammatories.

    Original languageEnglish
    Pages (from-to)249-251
    Number of pages3
    JournalMultiple Sclerosis
    Volume21
    Issue number2
    DOIs
    Publication statusPublished - 17 Feb 2015

    Keywords

    • Edema
    • Fingolimod
    • Multiple sclerosis
    • Steroid

    Fingerprint

    Dive into the research topics of 'Successful treatment of fingolimod-associated macular edema with intravitreal triamcinolone with continued fingolimod use'. Together they form a unique fingerprint.

    Cite this